Key Market Indicators
Belgian blood and blood forming organs medicine sales are predicted to reach $939.8 million by 2026. This is a 1.8% year-on-year growth on average since 2007. Belgium was ninth in the world rankings in 2021, with Greece coming in at number one with $840.1 million. Germany, Italy and South Korea respectively took second, third and fourth places. The prevalence of anemia in Belgium is expected to reach 13,070 hospital discharges by 2026, a 0.9% year-on-year growth rate since 2005. The country was 14th in the 2021 rankings, with the Czech Republic in first place at 12,350 hospital discharges. Germany, the United Kingdom and Poland took the second, third and fourth places respectively.
